Status:
UNKNOWN
3D Echocardiography and Cardiovascular Prognosis in Mitral Regurgitation
Lead Sponsor:
Haukeland University Hospital
Conditions:
Mitral Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
The 3D-PRIME study will analyse whether use of 3D echocardiography can improve risk stratification and cardiovascular outcome in patients with mitral regurgitation of different etiologies.
Eligibility Criteria
Inclusion
- Adult patients with primary or secondary mitral regurgitation (MR)
- MR of moderate or severe degree
- 3D echocardiographic examinations of \>= good spatial and temporal resolution
Exclusion
- Co-existence of another valve disease of severe degree
- Inability to give informed consent
Key Trial Info
Start Date :
April 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04442828
Start Date
April 17 2020
End Date
April 1 2025
Last Update
September 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, 5021